Albertina Pereira

Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Andrew T. Bender, A.S. Gardberg, Albertina Pereira et al. · Molecular Pharmacology · 2017 · 188 citations

Life Sciences, Immunology, Pharmacology +17

TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation

Andrew T. Bender, Evgeni P. Tzvetkov, Albertina Pereira et al. · ImmunoHorizons · 2020 · 118 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity

Jaromir Vlach, Andrew T. Bender, Melinda Przetak et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 86 citations · Full text

Life Sciences, Immunology, Medicinal Chemistry +15

Induction of Oligodendrocyte Differentiation and In Vitro Myelination by Inhibition of Rho-Associated Kinase

Carlos E. Pedraza, Christopher M. Taylor, Albertina Pereira et al. · ASN NEURO · 2014 · 57 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Btk inhibition treats TLR7/IFN driven murine lupus

Andrew T. Bender, Albertina Pereira, Kai Fu et al. · Clinical Immunology · 2016 · 54 citations · Full text

Life Sciences, Immunology, Pharmacology +17